Mach7 Technologies

Mach7 Technologies Rule of 40

The Rule of 40 of Mach7 Technologies (M7T.AX) as of Nov 11, 2026 is -45.05 %. In the previous year, Rule of 40 was 71.00 % — a change of -163.46% (lower).

Rule of 40

-45.05 %

YoY

-163.46%

Last updated:

Rule of 40 of Mach7 Technologies is 2026 -45.05 % . Rule of 40 of Mach7 Technologies was 2025 71.00 % . It decreases by -163.46% lower compared to the previous year.

The Mach7 Technologies Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2019
-75.37 AUD
Jan 1, 2020
97.45 AUD
Jan 1, 2021
-58.63 AUD
Jan 1, 2022
16.35 AUD
Jan 1, 2023
-13.58 AUD
Jan 1, 2024
-101.11 AUD
Jan 1, 2025
71.00 AUD
Jan 1, 2026
-45.05 AUD
The Mach7 Technologies Rule of 40 history
YEARRule of 40YoY
-45.05 %-163.46%
71.00 %-170.22%
-101.11 %+644.68%
-13.58 %-183.07%
16.35 %-127.88%
-58.63 %-160.16%
97.45 %-229.30%
-75.37 %-28.84%
-105.92 %-145.80%
231.26 %-73.63%
877.10 %-176.55%
-1,145.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Mach7 Technologies Stock analysis

What does Mach7 Technologies do? Mach7 Technologies Ltd. generates revenue through its medical imaging software and services for healthcare institutions. The company offers the Mach7 Enterprise Imaging Solution, which includes Enterprise Data Management, Enterprise Diagnostic Viewing, and Departmental Workflow applications. Enterprise Data Management features a Vendor Neutral Archive (VNA) and data administration tools for fast storage, access, retrieval, and viewing of images across healthcare networks with cloud connectivity. Enterprise Diagnostic Viewing provides consolidated access to patient images and data for healthcare professionals, enabling timely diagnosis and treatment. The company serves global healthcare enterprises across North America, Asia Pacific, and the Middle East regions. Mach7 Technologies Ltd. targets healthcare institutions as its primary customers, including hospitals and medical facilities that require advanced imaging and data management solutions. The core products, Mach7 Enterprise Imaging Solution and its components, are sold to these institutions to streamline workflows and improve patient care. The company's focus on global healthcare enterprises ensures a broad market reach in key regions, supporting its revenue streams through software licensing and service contracts. The principal activity of Mach7 Technologies Ltd. is the development and commercialization of medical imaging and data management software solutions. The firm's offerings are designed to meet the needs of healthcare enterprises by providing integrated tools for image storage, access, and diagnostic viewing. By focusing on the North America, Asia Pacific, and Middle East regions, the company capitalizes on the growing demand for efficient healthcare data management systems, driving sales of its software solutions to healthcare institutions. Mach7 Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mach7 Technologies stock

Rule of 40 of Mach7 Technologies is -45.05 % in 2026.

On Eulerpool you can find the complete historical development of Rule of 40 Mach7 Technologies since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Mach7 Technologies

All Key Metrics — Mach7 Technologies